Boeing expects slower production increase of 787 Dreamliner because of parts shortages

Boeing expects slower production increase of 787 Dreamliner because of parts shortages


Boeing 787 Dreamliners are built at the aviation company’s North Charleston, South Carolina, assembly plant on May 30, 2023. 

Juliette Michel | AFP | Getty Images

Boeing told employees on Monday that it expects a slower increase in production and deliveries of new 787 Dreamliner planes because of supplier shortages of “a few key parts.”

Boeing has already slowed down deliveries and output of its 737 Max planes in the aftermath of a near catastrophe in January when a door plug blew out from one of the jetliners mid-flight.

The company had separately been trying to boost output of 787 Dreamliners after quality problems suspended deliveries for nearly two years, ending in mid-2022.

“We continue to take steps to improve the overall health of our production system, putting into action your ideas for improving safety, first-pass quality, training, performing more work in sequence and ensuring our teams have the necessary resources to excel,” said Scott Stocker, 787 vice president and general manager, in a memo to staff at Boeing’s South Carolina 787 plant.

Stocker said Boeing is still facing supplier shortages.

“To that end, we have shared with our customers that we expect a slower increase in our rate of production and deliveries,” he wrote in the memo, reported earlier by Reuters, adding that the company still plans to increase the rate steadily because of high demand.

Boeing was producing about five 787 Dreamliners per month as of late last year and said in January it aimed to get up to 10 a month as early as next year.

Boeing is set to report quarterly results and will likely detail its production plans before the market opens on Wednesday.

Don’t miss these exclusives from CNBC PRO



Source

FDA commissioner defends agency’s drug approval decisions after wave of backlash
Business

FDA commissioner defends agency’s drug approval decisions after wave of backlash

Martin Makary, commissioner of the Food and Drug Administration (FDA), during a news conference at the US Food and Drug Administration headquarters in Silver Spring, Maryland, US, on Tuesday, April 28, 2026. Valerie Plesch | Bloomberg | Getty Images U.S. Food and Drug Administration Commissioner Marty Makary defended himself in a CNBC interview aired Tuesday […]

Read More
Property Play: Nvidia and PulteGroup are helping this startup put mini data centers on homes
Business

Property Play: Nvidia and PulteGroup are helping this startup put mini data centers on homes

A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight to your inbox. Even […]

Read More
Ford’s secret EV unit emerges from shadows, still bullish on new pickup amid market slowdown
Business

Ford’s secret EV unit emerges from shadows, still bullish on new pickup amid market slowdown

A Ford employee works inside a high voltage lab at Ford’s new Electric Vehicle Development Center in Long Beach, California. Courtesy Ford LONG BEACH, Calif. — As the global automotive industry retreats from all-electric vehicles after reporting billions of dollars in losses, Ford Motor continues to move forward with its next generation of EVs that […]

Read More